Suppressing Hyperinflammation in COVID-19 With JAK Inhibitors
Scientific evidence for and clinical experience of using JAK inhibitors in the treatment of COVID-19
Related Articles
Snapchat
Experts explain why continuing education, internal mobility and individualized career path are keys to professional development.
Esophageal Plaques and Systemic Sclerosis
Treatment for scleroderma can sometimes cause esophageal symptoms
Cleveland Clinic Surgeon Uses Novel Technique to Repair Nasal Septal Perforation
A nasal septal perforation repair using a novel approach offers patients another potential treatment option.
Multi-Ancestry Genetic Study of Parkinson’s Disease Identifies New Risk Genes in Pursuit of Novel Treatment Targets
International collaboration is most genetically diverse study of the disease to date
Moving Closer Toward Narcotic-Free Kidney Transplantation
Smaller incision may lead to reduced postoperative pain for some patients
Helping Women Become Leaders in Gastroenterology
Cleveland Clinic’s Chair of Gastroenterology shares her perspective on what it takes to become a leader in a specialty where women are underrepresented
Untreated Obstructive CAD Safe in TAVR Patients, Study Shows
New research from Cleveland Clinic shows that untreated stable obstructive coronary artery disease is safe in TAVR recipients. A TAVR-first approach may be a safe…
Case: When Central Nervous System Vasculitis Is Suspected
Holistic approach is necessary to ensure a correct diagnosis
Cleveland Clinic Plays Many Roles in Developing Pediatric-Specific Devices
Cleveland Clinic Children’s has embarked on several new initiatives for developing medical devices and technologies specifically for pediatric patients. Cleveland Clinic Children’s ambitious goal “to…
Novel Monoclonal Antibodies for NMOSD Show Strong Efficacy and Safety in Real-World Study
One of the first reports of real-world use of novel monoclonal antibodies for NMOSD confirms the efficacy and safety seen in their clinical trials.